Intracranial Hemorrhage During Dabigatran Treatment-Reference-Cited by-同舟云学术

Intracranial Hemorrhage During Dabigatran Treatment

Published:2014 Issue:6 Volume:78 Page:1335-1341
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Komori Motohiro¹,Yasaka Masahiro¹,Kokuba Kazuhito¹,Matsuoka Hideki²,Fujimoto Shigeru³,Yoshida Megumu⁴,Kameda Katsuharu⁵,Shono Tadahisa⁵,Nagata Shinji⁶,Ago Tetsuro⁷,Kitazono Takanari⁷,Okada Yasushi¹

Affiliation:

1. Department of Cerebrovascular Medicine and Neurology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center

2. Department of Cerebrovascular Medicine, National Hospital Organization Kagoshima Medical Center

3. Department of Cerebrovascular Medicine, Steel Memorial Yawata Hospital

4. Department of Cardiovascular Diseases, Shin-Kokura Hospital

5. Department of Neurosurgery, Hara Sanshin Hospital

6. Department of Neurosurgery, National Hospital Organization Kyushu Medical Center

7. Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/78/6/78_CJ-13-1534/_pdf

Reference23 articles.

1. 1. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139–1151 and Erratum in: N Engl J Med 2010; 363: 1877.

2. 2. Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation 2011; 123: 2363–2372.

3. 3. Lip GY, Lane DA. Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation: Focus on the elderly. Circ J 2013; 77: 1380–1388.

4. 4. Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, et al. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: A prospective, multicenter, observational study. Stroke 2008; 39: 1740–1745.

5. 5. Kuwashiro T, Yasaka M, Itabashi R, Nakagaki H, Miyashita F, Naritomi H, et al. Enlargement of acute intracerebral hematomas in patients on long-term warfarin treatment. Cerebrovasc Dis 2010; 29: 446–453.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Induced Cerebrovascular Disorders;Drug-induced Neurological Disorders;2021

2. Intracerebral hemorrhage outcomes in patients using direct oral anticoagulants versus vitamin K antagonists: a meta-analysis;Clinical Neurology and Neurosurgery;2020-11

3. Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease;Thrombosis and Haemostasis;2019-07-22

4. Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients;Journal of Clinical Neuroscience;2019-03

5. Prognosis for intracerebral hemorrhage during ongoing oral anticoagulant treatment;Acta Neurologica Scandinavica;2019-02-14